These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 150943)

  • 21. Disposition and metabolism of a novel antineoplastic agent, 4-tert-butyl-[3-(2-chloroethyl)ureido]benzene, in mice.
    Maurizis JC; Rapp M; Azim EM; Gaudreault RC; Veyre A; Madelmont JC
    Drug Metab Dispos; 1998 Feb; 26(2):146-51. PubMed ID: 9456301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition and metabolism in 1-(2-chloroethyl)-3-(2',3',4'-tri-o-acetyl, ribopyranosyl)-1-nitrosourea in rats.
    Godeneche D; Moreau MF; Madelmont JC; Duprat J; Plagne R
    Cancer Res; 1982 Feb; 42(2):525-9. PubMed ID: 6799188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic activity of MCNU: a new antitumor agent.
    Sekido S; Ninomiya K; Iwasaki M
    Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-phosphate in mice and dogs.
    Noker PE; Duncan GF; El Dareer SM; Hill DL
    Cancer Treat Rep; 1983 May; 67(5):445-56. PubMed ID: 6189605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiological disposition and metabolism of O-ethyl-O-4-nitrophenyl phenylphosphonothioate in male cats following a single dermal administration.
    Abou-Donia MB; Kinnes CG; Abdo KM; Bjornsson TD
    Drug Metab Dispos; 1983; 11(1):31-6. PubMed ID: 6132792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of ethimizol, a nootropic drug, in rats and mice.
    Trnovec T; Durisová M; Bezek S; Burdáts P; Marko V; Faberová V; Zemánek M; Soltés L; Piotrovsky LB
    Drug Metab Dispos; 1986; 14(6):718-23. PubMed ID: 2877833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of ciprofloxacin on the disposition of 14C-dideoxyinosine-derived radioactivity in the rat.
    Gallicano KD; Buttar HS; Moffatt JH
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):163-74. PubMed ID: 8321920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
    Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE
    J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
    Noker PE; Hill DL; Kalin JR; Temple CG; Montgomery JA
    Drug Metab Dispos; 1985; 13(6):677-81. PubMed ID: 2867870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutagenic activity of nitrosourea antitumor agents.
    Franza BR; Oeschger NS; Oeschger MP; Schein PS
    J Natl Cancer Inst; 1980 Jul; 65(1):149-54. PubMed ID: 6446611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A structure-activity analysis of chemical and biological parameters of chloroethylnitrosoureas in mice.
    Panasci LC; Green D; Nagourney R; Fox P; Schein PS
    Cancer Res; 1977 Aug; 37(8 Pt 1):2615-8. PubMed ID: 141323
    [No Abstract]   [Full Text] [Related]  

  • 34. Disposition and distribution of platinum following parenteral administration of cis-dichlorodiammineplatinum(II) to animals.
    Litterst CL; LeRoy AF; Guarino AM
    Cancer Treat Rep; 1979; 63(9-10):1485-92. PubMed ID: 498147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and metabolism of a novel antifibrotic drug pirfenidone, in mice following intravenous administration.
    Giri SN; Wang Q; Xie Y; Lango J; Morin D; Margolin SB; Buckpitt AR
    Biopharm Drug Dispos; 2002 Jul; 23(5):203-11. PubMed ID: 12116052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.
    Hayat M; Bourut C; Chenu E; Montero JL; Imbach JL; MacDonald JS; Mathé G
    Cancer Chemother Pharmacol; 1979; 3(4):217-21. PubMed ID: 161207
    [No Abstract]   [Full Text] [Related]  

  • 39. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.
    Cossum PA; Sasmor H; Dellinger D; Truong L; Cummins L; Owens SR; Markham PM; Shea JP; Crooke S
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1181-90. PubMed ID: 8166890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.